Abstract
The objective was to evaluate the influence of varying plasma progesterone (P 4) concentrations throughout the luteal phase in dairy cows on PGF 2α production (assessed as plasma concentrations of 13,14-dihydro-15-keto-PGF 2α; PGFM) following treatment with estradiol-17β (E 2) or oxytocin (OT). In all experiments, time of ovulations was synchronized with the OvSynch protocol and Day 0 corresponded to day of second GnRH injection. In Experiment 1, non-lactating dairy cows on Day 6 remained non-treated ( n = 9), received 20 mg LH ( n = 7), or had ovarian follicles larger than 6 mm aspirated ( n = 8). In Experiment 2, cows on Day 6 were untreated ( n = 9) or received 5000 IU hCG ( n = 10). In Experiments 1 and 2, all cows received 3 mg E 2 on Day 17, and blood samples were collected every 30 min from 2 h before to 10 h after E 2. Experiment 3 was conducted in two periods, each from Days 0 to 17 of the estrous cycle. At the end of Period 1, animals switched treatments in a crossover arrangement. Animals in Group 2/8 ( n = 4) received 2 kg/d of concentrate in the first period and 8 kg/d in the second period. Animals in Group 8/2 ( n = 7) received the alternate sequence. Blood was collected daily for measurement of P 4 4 h after concentrate feeding. On Day 17, blood was collected from 1 h before to 1 h after a 100 IU OT injection. In Experiment 1, both plasma P 4 and release of PGF 2α were similar between LH-treated and control cows ( P > 0.10). In Experiment 2, plasma P 4 was elevated to a greater extent on Day 17 in cows treated with hCG ( P < 0.05) and plasma PGFM was also greater in hCG-treated animals (treatment × time interaction; P < 0.05). In Experiment 3, there was a group × period interaction ( P < 0.01) for plasma P 4, indicating that less concentrate feeding was associated with greater plasma P 4. Release of PGF 2α in response to OT was greater for cows receiving less concentrate (group × period interaction; P < 0.05). In conclusion, dairy cows with more elevated blood P 4 concentrations released more PGF 2α in response to E 2 or OT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.